Elixinol Wellness Reports Record $4.3 Million Q2 FY26 Revenue Boosted by Priceline Partnership and Premium Nutrition Growth

Record Quarterly Revenue Reflects Strategic Portfolio Restructuring

Elixinol Wellness posted record quarterly revenue of $4.3 million in Q2 FY26, a 5% increase over the prior corresponding period. This achievement follows the company’s strategic transformation and portfolio restructuring, which involved exiting legacy US CBD operations. The revenue growth underscores disciplined execution of a strategy focused on enhancing earnings quality and establishing a more profitable business model. Emphasis on higher-margin revenue streams and an optimised channel mix contributed to the improved financial results.

Revenue growth was accompanied by effective cost management and operational efficiency improvements. Customer cash receipts reached $3.9 million in Q2 FY26, a 9% increase from the previous quarter, indicating strong underlying business momentum and sustained demand for Elixinol’s wellness and nutrition products. The company anticipates continued positive revenue momentum into Q3 FY26, supported by new business-to-business and retail channel opportunities.

The Healthy Chef Brand Leads Premium Product Growth and Channel Expansion

The Healthy Chef, Elixinol’s flagship premium nutrition brand, was the standout performer in Q2 FY26, generating $1.15 million in revenue—a 20% increase year-on-year and 26% growth quarter-on-quarter. The brand now represents 27% of total group revenue, up from 23% in the equivalent quarter last year, reflecting a strategic shift towards premium owned brands and direct channels. This aligns with the company’s portfolio repositioning and strong consumer demand for science-backed, high-quality wellness products.

The Healthy Chef’s expansion into the Priceline Pharmacy retail network marks a key channel development, enhancing brand visibility and consumer access in a high-traffic retail setting. Within the portfolio, specific product lines gained momentum: Metabolic Burn, launched in Q1 FY26, performed strongly, tapping into the emerging pre-glycemic-lipid profile (pre-GLP-1) nutrition category. Protein Water also maintained solid growth, reinforcing the company’s strategy to grow its premium nutritional product range targeting health-conscious consumers seeking functional benefits.

Gross Margin Growth Highlights Revenue Quality and Channel Optimisation

Gross margin improved markedly to 45% in Q2 FY26, up 8 percentage points from 38% in Q2 FY25. This reflects effective portfolio management, reduced reliance on lower-margin contracts and SKUs, and increased sales from higher-margin e-commerce channels. Gross profit rose 26% year-on-year to $2.0 million, compared with $1.6 million in Q2 FY25. The Australian segment delivered especially strong gross profit growth, up 36% year-on-year, highlighting the success of geographic and channel optimisation strategies.

This margin expansion demonstrates Elixinol’s ability to enhance profitability through strategic channel management and portfolio curation rather than relying solely on revenue growth. By prioritising owned brands and direct-to-consumer channels, the company has shifted its revenue mix toward higher-quality earnings with improved sales returns. This focus on premium functional nutrition products, supported by scientific research and clinical validation, enables premium pricing and superior gross margins.

Operating Cost Reductions Bolster Cash Flow Improvements

Elixinol Wellness reduced its operating cost base by 23% year-on-year, reflecting disciplined cost control across all major expense categories. Employee costs decreased by 23%, distribution expenses fell by 25%, marketing spend dropped 32%, and administration and corporate costs improved by 15%. These reductions stem from the company’s business simplification strategy executed during financial restructuring, representing a structural change rather than temporary cuts.

Reported net operating cash outflow for the quarter was $0.58 million, which included non-recurring expenses such as out-of-cycle payments, interest on secured loan notes, and Annual General Meeting costs. After adjusting for these items, underlying operating cash flow was positive $0.05 million, marking the third consecutive quarter of positive underlying cash flow and an improvement of approximately $0.71 million compared to Q2 FY25, when the underlying cash outflow was $0.66 million. This sustained cash flow improvement supports the company’s goal of sustainable profitability and reduced external financing dependence.

Expanding Into Longevity and Bioactive Peptide Nutrition

Elixinol is advancing The Healthy Chef’s expansion into the longevity and metabolic health sector, targeting the "peptide curious" consumer segment. This strategy addresses a significant market opportunity for precision functional nutrition products that support appetite regulation, muscle preservation, recovery, and sleep without pharmaceutical injectable treatments like GLP-1 medications. The company is developing formulations using clinically studied bioactive peptides and other science-backed ingredients to meet growing consumer demand.

The successful launch of Metabolic Burn validates this strategic direction, showing consumer willingness to pay premium prices for clinically supported functional nutrition products. Elixinol’s emphasis on science-backed formulations differentiates its offerings in a crowded wellness market and supports premium positioning and higher gross margins. This longevity and metabolic health expansion taps into demographic trends of aging populations and rising interest in preventive health management through nutrition.

Cash Position and Financial Management

As of 30 June 2026, Elixinol Wellness held $1.0 million in cash. The company did not specify allocations or detailed cash flow forecasts for upcoming quarters. Related party payments totaled $0.13 million during the quarter, covering director fees and executive remuneration, as disclosed in Item 6.1 of the Appendix 4C cash flow statement. The company maintains a secured loan note facility, with interest payments impacting quarterly cash flows.

Elixinol’s focus on sustained positive underlying operating cash flow across consecutive quarters indicates a path toward reduced external financing reliance and enhanced financial flexibility. As revenue scales within the optimised operating model, further cash flow improvements are expected, potentially enabling capital investments or debt reduction. The achievement of three consecutive quarters of positive underlying cash flow, despite a modest cash balance, signals operational progress and business sustainability.

Strategic Position in Sustainable Nutrition and Wellness Sector

Elixinol Wellness is a leading player in sustainable nutrition and wellness, operating across e-commerce, retail partnerships, and business-to-business channels. Its portfolio includes multiple premium brands, with The Healthy Chef as the largest and fastest-growing. The business model combines owned brands with distribution partnerships, providing consumer access through physical retail, online marketplaces, and pharmacy channels. This multi-channel approach reduces dependency on any single distribution path and enhances business resilience.

The company’s strategic focus on premium functional nutrition differentiates it from mass-market competitors. Emphasising clinical validation, science-backed ingredients, and targeted functionality appeals to health-conscious consumers willing to pay premium prices for proven efficacy and quality. This positioning supports the superior gross margins reported and distinguishes Elixinol in an increasingly competitive wellness market. Expansion into emerging categories like longevity nutrition and bioactive peptides positions the company in high-growth segments.

Upcoming Milestones and Strategic Priorities

Looking ahead to Q3 FY26, Elixinol plans to sustain revenue growth through channel expansion and product innovation. Key priorities include maintaining disciplined cost management to support positive underlying operating cash flow, accelerating organic growth via The Healthy Chef’s precision nutrition positioning, and evaluating strategic business development or partnership opportunities. The company anticipates positive revenue momentum in the coming quarter, driven by new business-to-business and retail channels, though it has not provided specific revenue guidance.

The board remains committed to disciplined capital allocation and organic growth, focusing on The Healthy Chef’s expansion within the precision nutrition category, including bioactive peptides and science-backed functional ingredients. This strategy reflects confidence in market potential and the company’s ability to commercialise premium functional nutrition products. Management continues to explore inorganic growth opportunities through partnerships or acquisitions to complement the existing portfolio and enhance shareholder value.

Financial Performance Commentary from Leadership

Elixinol Wellness Chair Gavin Evans expressed satisfaction with Q2 FY26 progress, noting that management has successfully repositioned the business around stronger brands, higher-margin revenue streams, and a leaner cost base over the past year. He highlighted that these efforts are translating into improved financial performance, enhanced underlying cash generation, and a more resilient operating platform. The board’s assessment reflects confidence in the sustainability of recent improvements and strategic direction, emphasizing fundamental business quality enhancements and long-term value creation.

CEO Natalie Butler described Q2 FY26 as another quarter of strategic progress, underscoring The Healthy Chef portfolio’s strong performance and the positive impact of the Priceline Pharmacy expansion. She noted continued momentum in premium functional nutrition products like Metabolic Burn and Protein Water. Butler also highlighted ongoing business simplification and operating cost reductions, which contributed to significant underlying operating cash flow improvements compared to the prior year. Her remarks reinforce the board’s positive outlook on operational momentum and financial performance.